General Price Increase for Lonza Microbial Control Products in Europe

December 02,2010 Basel, Switzerland

Effective 1 December 2010 or as contracts allow, Lonza Microbial Control Europe adjusts prices of the following products : BarquatTM, LonzabacTM and AcrawaxTM C.

Price increases will be up to 15%. The increases are a result of increased raw material costs such as Palm Kernel Oil, mid-cut alcohol and tallow.

 

About Lonza

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharma-ceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based re-search, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2009, the company had sales of CHF 2.690 billion. Further information can be found at www.lonza.com.

 

For further information:

Business Unit Microbial Control
Betrand Thinus
Tel. +41 61 316-8886
Fax +41 61 316-9886
bertrand.thinus@lonza.com

Corporate Communications
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9798
dominik.werner@lonza.com

Browse All News
Bg